B. Riley Wealth Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-16,050
| Closed | -$436K | – | 1569 |
|
2024
Q1 | $436K | Buy |
+16,050
| New | +$436K | 0.01% | 863 |
|
2023
Q4 | – | Sell |
-16,050
| Closed | -$436K | – | 1494 |
|
2023
Q3 | $436K | Sell |
16,050
-6,650
| -29% | -$180K | 0.01% | 863 |
|
2023
Q2 | $698K | Buy |
22,700
+9,050
| +66% | +$278K | 0.02% | 711 |
|
2023
Q1 | $492K | Sell |
13,650
-5,500
| -29% | -$198K | 0.01% | 807 |
|
2022
Q4 | $757K | Sell |
19,150
-3,000
| -14% | -$119K | 0.02% | 640 |
|
2022
Q3 | $890K | Buy |
22,150
+8,500
| +62% | +$342K | 0.03% | 541 |
|
2022
Q2 | $574K | Buy |
13,650
+2,100
| +18% | +$88.3K | 0.02% | 602 |
|
2022
Q1 | $450K | Sell |
11,550
-14,330
| -55% | -$558K | 0.01% | 805 |
|
2021
Q4 | $1.03M | Sell |
25,880
-9,400
| -27% | -$375K | 0.03% | 521 |
|
2021
Q3 | $1.28M | Buy |
+35,280
| New | +$1.28M | 0.04% | 448 |
|